Joel Sendek
Chief Financial Officer · Perspective Therapeutics, Inc.
- 2025
- Sep 4, 2025
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joel Sendek files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lantheus Alpha Therapy, LLC - $1.13M in CATX purchases and sales in the last 12 months
- Lantheus Holdings, Inc. - $357K in CATX purchases and sales in the last 12 months
- Jonathan Robert Hunt - $22K in CATX purchases and sales in the last 12 months
- Robert F. Williamson III - $20K in CATX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joel Sendek?
Joel Sendek is a corporate insider, tracked as Chief Financial Officer of Perspective Therapeutics, Inc. (CATX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Joel Sendek last file a Form 4?
The only primary Form 4 on record is dated 4 September 2025.